Literature DB >> 19103563

Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives.

Garima Chawla1, Arvind K Bansal.   

Abstract

Irbesartan (IBS) is a hydrophobic drug with poor aqueous solubility and dissolution rate. Solid dispersions (SDs) of IBS were prepared with both small molecules (tartaric acid and mannitol) and polymeric additives (polyvinyl-pyrrolidone, PVP, and hydroxypropyl methylcellulose, HPMC). A 9.5 and 7 folds enhancement in solubility over the crystalline form (14.6 microg mL-1) was observed for tartaric acid (138 microg mL-1) and PVP (103 microg mL-1), respectively. Powder X-ray diffraction confirmed that IBS existed in the glassy state in all cases, even with excipients having low glass transition temperature. Thermal methods (differential scanning calorimetry and hot stage microscopy) were used to evaluate the miscibility of the drug and additives. These techniques suggested that tartaric acid led to generation of >>amorphous solutions<< in contrast to >>amorphous suspensions<< in other three cases. The in vitro dissolution of IBS depended on the additive load and increased with increasing concentration in the case of tartaric acid, an acidifying excipient. The results indicate the suitability of even small molecules for providing solubility benefits, which can be attributed to the good glass forming ability and reasonable ability of IBS to remain in the glassy state.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19103563     DOI: 10.2478/v10007-008-0016-1

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  4 in total

1.  Multicomponent amorphous nanofibers electrospun from hot aqueous solutions of a poorly soluble drug.

Authors:  Deng-Guang Yu; Li-Dong Gao; Kenneth White; Christopher Branford-White; Wei-Yue Lu; Li-Min Zhu
Journal:  Pharm Res       Date:  2010-08-19       Impact factor: 4.200

2.  Pediatric suppositories of sulpiride solid dispersion for treatment of Tourette syndrome: in vitro and in vivo investigations.

Authors:  Ahmed S Zidan; Sherif E Emam; Tamer M Shehata; Fakhr-eldin S Ghazy
Journal:  AAPS PharmSciTech       Date:  2014-12-11       Impact factor: 3.246

3.  Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan.

Authors:  Jaydeep Patel; Anjali Patel; Mihir Raval; Navin Sheth
Journal:  J Adv Pharm Technol Res       Date:  2011-01

Review 4.  Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs.

Authors:  Xingwang Zhang; Huijie Xing; Yue Zhao; Zhiguo Ma
Journal:  Pharmaceutics       Date:  2018-06-23       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.